Aberrant cytokine signaling in leukemia

85Citations
Citations of this article
89Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abnormalities of cytokine and growth factor signaling pathways are characteristic of all forms of leukemia: lymphoid and myeloid, acute and chronic. In normal hematopoietic cells, cytokines provide the stimulus for proliferation, survival, self-renewal, differentiation and functional activation. In leukemic cells, these pathways are usurped to subserve critical parts of the malignant program. In this review, our current knowledge of leukemic cell cytokine signaling will be summarized, and some speculations on the significance and implications of these insights will be advanced. A better understanding of aberrant cytokine signaling in leukemia should provide additional targets for the rational therapy of these diseases. © 2007 Nature Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Van Etten, R. A. (2007, October 15). Aberrant cytokine signaling in leukemia. Oncogene. https://doi.org/10.1038/sj.onc.1210758

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free